Live Quote · NASDAQADVMHealthcare· Biotechnology

Adverum Biotechnologies, Inc.

$4.36 0.00%(+$0.00)
TickerSpark Score
44/100
Weak
60
Valuation
40
Profitability
10
Growth
52
Health
60
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ADVM research report →

52-Week Range60% of range
Low
$1.78
Current
$4.36
High
$6.07
Company Overviewwww.adverum.com

About the company

Adverum Biotechnologies, Inc. is a clinical-phase biotechnology firm primarily engaged in discovering and advancing gene therapies. The company's mission is to create innovative treatments for various eye-related conditions and uncommon illnesses.

CEO
Laurent Fischer
IPO
2014
Employees
155
HQ
Redwood City, CA, US

Price Chart

-26.23% · this period
$5.93$3.99$2.05Dec 06Jun 11Dec 09
Valuation
Market Cap
$96.26M
P/E
-0.71
P/S
0.00
P/B
-1.84
EV/EBITDA
-1.12
Div Yield
0.00%
Profitability
Gross Margin
0.00%
Op Margin
0.00%
Net Margin
0.00%
ROE
872.77%
ROIC
-433.57%
Growth & Income
Revenue
$1.00M · -72.22%
Net Income
$-130,927,000 · -7.22%
EPS
$-6.62 · -227.72%
Op Income
$-139,159,000
FCF YoY
-1.24%
Performance & Tape
52W High
$6.07
52W Low
$1.78
50D MA
$4.41
200D MA
$3.48
Beta
0.87
Avg Volume
724.34K

Get TickerSpark's AI analysis on ADVM

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Form 4 · Filings

Recent insider transactions

Who's buying, who's selling, and how much.

DateInsiderTypeShares
Dec 9, 25Fischer Laurentother500,000
Dec 9, 25Fischer Laurentother150,000
Dec 9, 25Fischer Laurentother25,000
Dec 9, 25Fischer Laurentother150,000
Dec 9, 25Fischer Laurentsell200,000
Dec 9, 25Fischer Laurentsell93,000
Dec 9, 25Fischer Laurentother351,513
Dec 9, 25Fischer Laurentother522,666
Dec 9, 25Fischer Laurentsell110,420
Dec 9, 25Soparkar Peterother150,000
Coverage · ADVM

Our ADVM coverage

Recent articles, reports, and earnings notes.

On-Demand Research

No research on ADVM yet

For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.

Generate ADVM report →
Internal Compare

Similar companies

Peers in the same neighborhood.